Provided by Tiger Trade Technology Pte. Ltd.

Astria Therapeutics Inc

12.58
0.0000
Volume:- -
Turnover:40.15M
Market Cap:718.13M
PE:-5.88
High:12.58
Open:12.58
Low:12.58
Close:12.58
52wk High:13.29
52wk Low:3.56
Shares:57.08M
Float Shares:38.38M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1381
EPS(LYR):-1.6784
ROE:-43.15%
ROA:-26.94%
PB:2.47
PE(LYR):-7.50

Loading ...

Astria Therapeutics' Final Phase 1b/2 Trial Results For Hereditary Angioedema Treatment Show Strong Efficacy

MT Newswires Live
·
Nov 07, 2025

Astria Therapeutics announces final results from ALPHA-STAR trial

TIPRANKS
·
Nov 06, 2025

Astria Therapeutics Reports Positive Phase 1b/2 Trial Results for Navenibart in HAE Patients

Reuters
·
Nov 06, 2025

Astria Therapeutics Announces Final Positive Results From All Enrolled Hae Patients in the Alpha-Star Phase 1B/2 Trial of Navenibart

THOMSON REUTERS
·
Nov 06, 2025

Astria Therapeutics Inc - Trial Shows Robust Attack Rate Reduction and Favorable Safety Profile

THOMSON REUTERS
·
Nov 06, 2025

BioCryst Pharmaceuticals reports Q3 ORLADEYO net revenue of $159.1 million and operating profit of $29.6 million

Reuters
·
Nov 03, 2025

13D Filings -- Barrons.com

Dow Jones
·
Nov 01, 2025

Astria Therapeutics to Present Final ALPHA-STAR Trial Results for Navenibart in Hereditary Angioedema

Reuters
·
Oct 31, 2025

Astria Therapeutics (ATXS) Gets a Buy from LifeSci Capital

TIPRANKS
·
Oct 18, 2025

Astria Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
Oct 16, 2025

Astria Therapeutics : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
Oct 15, 2025

Astria Therapeutics Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $13 From $30

THOMSON REUTERS
·
Oct 15, 2025

BioCryst’s Strategic Acquisition of ATXS: A Catalyst for Long-Term Growth and Profitability

TIPRANKS
·
Oct 15, 2025

Astria Therapeutics Cut to Hold From Buy by Jefferies

Dow Jones
·
Oct 15, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Spyre Therapeutics, Astria, Walmart

Reuters
·
Oct 15, 2025

Sector Update: Health Care Stocks Higher Tuesday Afternoon

MT Newswires Live
·
Oct 15, 2025

Astria Therapeutics Up Nearly 39%, on Pace for Largest Percent Increase Since January 2021 -- Data Talk

Dow Jones
·
Oct 15, 2025

Here’s Why Astria Therapeutics Stock (ATXS) Exploded Today

TIPRANKS
·
Oct 14, 2025

BioCryst Pharmaceuticals Shares Down 3%

THOMSON REUTERS
·
Oct 14, 2025

BioCryst Pharmaceuticals Shares Down 9.5% Premarket

THOMSON REUTERS
·
Oct 14, 2025